Skip to main content

Advertisement

SpringerLink
Log in

The prevalence of systemic sclerosis is increased among patients with alopecia areata: a population-based study

  • Original Article
  • Published:
Immunologic Research Aims and scope Submit manuscript

Abstract

Although the coexistence of alopecia areata (AA) and systemic sclerosis (SSc) has been anecdotally reported, the association between these conditions has been poorly investigated. We aimed to assess the association between AA and SSc using a large-scale real-life computerized database. A cross-sectional study was conducted comparing the prevalence of SSc among patients with AA and among age-, sex-, and ethnicity-matched control subjects. Chi-square and t tests were used for univariate analysis, and logistic regression model was used for multivariate analysis. The study was performed utilizing the computerized database of Clalit Health Services ensuring 4.4 million subjects. A total of 51,561 patients with AA and 51,410 controls were included in the study. The prevalence of SSc was increased in patients with AA as compared with the control group (0.1% vs. 0.0%, respectively; OR, 2.30; 95% CI, 1.2–4.4; P = 0.010). The association was stronger among older and Jewish patients. In a multivariate analysis adjusting for sex, age, ethnicity, and other comorbidities, AA was still independently associated with SSc (OR, 2.3; 95% CI, 1.2–4.4; P = 0.012). In conclusion, a significant positive association was revealed between AA and SSc. Further studies are necessary to establish these findings in other study populations and to elucidate the mechanism underlying this association. Awareness of SSc may be of importance for physicians treating patients with AA, and screening for SSc in patients with relevant symptoms may be considered.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Villasante Fricke AC, Miteva M. Epidemiology and burden of alopecia areata: a systematic review. Clin Cosmet Investig Dermatol. 2015;24(8):397–403. https://doi.org/10.2147/CCID.S53985.

  2. Paus R, Bertolini M. The role of hair follicle immune privilege collapse in alopecia areata: status and perspectives. J Investig Dermatol Symp Proc. 2013;16(1):S25–7.

    Article  CAS  Google Scholar 

  3. Biran R, Zlotogorski A, Ramot Y. The genetics of alopecia areata: new approaches, new findings, new treatments. J Dermatol Sci. 2015;78(1):11–20. https://doi.org/10.1016/j.jdermsci.2015.01.004.

    Article  CAS  Google Scholar 

  4. Lee S, Lee H, Lee CH, Lee WS. Comorbidities in alopecia areata: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(2):466–477.e16.

    Article  Google Scholar 

  5. Desbois AC, Cacoub P. Systemic sclerosis: an update in 2016. Autoimmun Rev. 2016;15(5):417–26.

    Article  Google Scholar 

  6. The Lancet. Systemic sclerosis: advances and prospects. Lancet. 2017;7;390(10103):1624.

  7. Kayser C, Fritzler MJ. Autoantibodies in systemic sclerosis: unanswered questions. Front Immunol. 2015 ;15(6):167.

  8. Czirják L, Foeldvari I, Müller-Ladner U. Skin involvement in systemic sclerosis. Rheumatology (United Kingdom). 2008;47 Suppl 5:v44–5.

    Article  Google Scholar 

  9. Rennert G, Peterburg Y. Prevalence of selected chronic diseases in Israel. Isr Med Assoc J. 2001 [cited 2017 Jan 30];3:404–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11433630.

  10. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic dis. 1987;40:373–83 Available from: http://www.ncbi.nlm.nih.gov/pubmed/3558716.

    Article  CAS  Google Scholar 

  11. Watad A, Bragazzi NL, Adawi M, Aljadeff G, Amital H, Comaneshter D, et al. Anxiety disorder among rheumatoid arthritis patients: insights from real-life data. J Affect Disord. 2017;213:30–4.

    Article  Google Scholar 

  12. Somers EC, Thomas SL, Smeeth L, Hall AJ. Autoimmune diseases co-occurring within individuals and within families: a systematic review. Epidemiology. 2006;17:202–17.

    Article  Google Scholar 

  13. Szyper-Kravitz M, Marai I, Shoenfeld Y. Coexistence of thyroid autoimmunity with other autoimmune diseases: friend or foe? Additional aspects on the mosaic of autoimmunity. Autoimmunity. 2005;38:247–55.

    Article  CAS  Google Scholar 

  14. Davidson A, Diamond B. Autoimmune diseases. New Engl J Med. 2001;345:340–50 Available from: http://www.ncbi.nlm.nih.gov/pubmed/11484692.

    Article  CAS  Google Scholar 

  15. Molano-González N, Rojas M, Monsalve DM, Pacheco Y, Acosta-Ampudia Y, Rodríguez Y, et al. Cluster analysis of autoimmune rheumatic diseases based on autoantibodies. New insights for polyautoimmunity. J Autoimmun. 2019;98:24–32.

    Article  Google Scholar 

  16. Seo HM, Han SS, Kim JS. Cancer risks among patients with alopecia areata: a population-based case-control study in Korea. J Am Acad Dermatol. 2018;78(1):209–211.

    Article  Google Scholar 

  17. Serarslan G, Savaş N, Yenin JZ. Is atopy and autoimmunity more prevalent in patients with alopecia areata? A comparative study. J Eur Acad Dermatol Venereol. 2012;26(6):720–3.

    Article  Google Scholar 

  18. Thomas E, Kadyan R. Alopecia areata and autoimmunity: a clinical study. Indian J Dermatol. 2008;53(2):70–4.

    Article  Google Scholar 

  19. Robinson D, Eisenberg D, Nietert PJ, Doyle M, Bala M, Paramore C, et al. Systemic sclerosis prevalence and comorbidities in the US, 2001–2002. Curr Med Res Opin. 2008;24(4):1157–66.

    Article  Google Scholar 

  20. Watad B, McGonagle D, Comaneshter C, et al. Systemic sclerosis is linked to psoriasis and may impact on patients’ survival: a large cohort study. J Clin Med. 2019;8(4):521.

    Article  Google Scholar 

  21. Thompson DM, Robinson TW, Lennard-Jones J. Alopecia areata, vitiligo, scleroderma and ulcerative colitis. Proc R Soc Med. Royal Society of Medicine Press; 1974 [cited 2019 Jul 31];67:1010–2. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4154458.

  22. Shellow Wvr, Edwards Je, Koo Jym. Profile of alopecia areata: a questionnaire analysis of patient and family. Int J Dermatol. 1992 [cited 2019 Jul 31];31:186–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1568816.

    Article  CAS  Google Scholar 

  23. Chu SY, Chen YJ, Tseng WC, Lin MW, Chen TJ, Hwang CY, et al. Comorbidity profiles among patients with alopecia areata: the importance of onset age, a nationwide population-based study. J Am Acad Dermatol. 2011;65(5):949–56.

    Article  Google Scholar 

  24. Barahmani N, Schabath MB, Duvic M. History of atopy or autoimmunity increases risk of alopecia areata. J Am Acad Dermatol. 2009;61(4):581–91.

    Article  Google Scholar 

  25. Gilhar A, Paus R, Kalish RS. Lymphocytes, neuropeptides, and genes involved in alopecia areata. J Clin Invest. 2007;117(8):2019–27.

    Article  CAS  Google Scholar 

  26. Antonelli A, Ferri C, Fallahi P, Colaci M, Giuggioli D, Ferrari SM, et al. Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis. J Rheumatol. 2008;35(9):1809–11.

  27. Oliver SJ. The Th1/Th2 paradigm in the pathogenesis of scleroderma, and its modulation by thalidomide. Curr Rheumatol Rep. 2000;2(6):486–91.

    Article  CAS  Google Scholar 

  28. O’Reilly S, Hügle T, Van Laar JM. T cells in systemic sclerosis: a reappraisal. Rheumatology (United Kingdom). 2012;51(9):1540–9.

    Article  CAS  Google Scholar 

  29. Petukhova L, Duvic M, Hordinsky M, Norris D, Price V, Shimomura Y, et al. Genome-wide association study in alopecia areata implicates both innate and adaptive immunity. Nature. 2010;1;466(7302):113–7.

    Article  CAS  Google Scholar 

  30. Diaz-Gallo LM, Simeon CP, Broen JC, Ortego-Centeno N, Beretta L, Vonk MC, et al. Implication of IL-2/IL-21 region in systemic sclerosis genetic susceptibility. Ann Rheum Dis. 2013;72(7):1233–8.

    Article  Google Scholar 

  31. Ramos PS, Silver RM, Feghali-Bostwick CA. Genetics of systemic sclerosis: recent advances. Curr Opin Rheumatol. 2015;27(6):521–9.

    Article  CAS  Google Scholar 

  32. Chan LS, Vanderlugt CJ, Hashimoto T, Nishikawa T, Zone JJ, Black MM, et al. Epitope spreading: lessons from autoimmune skin diseases. J Invest Dermatol. 1998;110(2):103–9.

    Article  CAS  Google Scholar 

  33. Höfler M. The Bradford Hill considerations on causality: a counterfactual perspective. Emerg Themes Epidemiol. 2005;2:11. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1291382&tool=pmcentrez&rendertype=abstract.

    Article  Google Scholar 

  34. Birkenfeld S, Dreiher J, Weitzman D, Cohen AD. Coeliac disease associated with psoriasis. Br J Dermatol. 2009;161:1331–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19785615.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, Rambam Health Care Campus, POB 9602, 31096, Haifa, Israel

    Khalaf Kridin

  2. Department of Behavioral Sciences, Ariel University, Ariel, Israel

    Dana Tzur Bitan

  3. Siaal Research Center for Family Medicine and Primary Care, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel

    Doron Comaneshter & Arnon D. Cohen

  4. Department of Quality Measurements and Research, Chief Physician’s Office, Clalit Health Services, Tel Aviv, Israel

    Arnon D. Cohen

Authors
  1. Khalaf Kridin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dana Tzur Bitan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Doron Comaneshter
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Arnon D. Cohen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Khalaf Kridin.

Ethics declarations

Conflict of interest

ADC served as an advisor, investigator, or speaker for Abbvie, BI, Dexcel Pharma, Janssen, Novartis, Perrigo, Pfizer, and Rafa. None of the other authors have any conflicts of interest to declare.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kridin, K., Tzur Bitan, D., Comaneshter, D. et al. The prevalence of systemic sclerosis is increased among patients with alopecia areata: a population-based study. Immunol Res 67, 368–372 (2019). https://doi.org/10.1007/s12026-019-09104-9

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12026-019-09104-9

Keywords

Search

Navigation